Atlas Trials

Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell Carcinoma

Clinical trial NCT06690476 · RECRUITING

Trial details

NCT number
NCT06690476
Sponsor
Peking University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma
Start date
2024-10-10
Primary completion
2026-07-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.